The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Solucion InterSol
Solucion aditiva para plaquetas 3 · SODIUM CHLORIDE 452 mg/100mL; SODIUM ACETATE 442 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL · Solution · Intravenous · Fenwal, Inc.
NDC 00942-9603-12 · 500 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Fenwal International, Inc.United Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BN080041
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Solucion aditiva para plaquetas 3 (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fenwal, Inc. | SODIUM CHLORIDE 452 mg/100mL; SODIUM ACETATE 442 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
| Fenwal, Inc. | SODIUM CHLORIDE 442 mg/100mL; SODIUM ACETATE 452 mg/100mL; TRISODIUM CITRATE DIHYDRATE 305 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 93 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 318 mg/100mL | Jul 22, 2026 | Aug 19, 2026 |
| Fenwal, Inc. | SODIUM ACETATE 442 mg/100mL; SODIUM CHLORIDE 452 mg/100mL; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 305 mg/100mL; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL; TRISODIUM CITRATE DIHYDRATE 318 mg/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Solucion InterSol — NDC 00942-9603-12," retrieved September 3, 2026, https://drugdashboards.com/drug/00942960312.
Free to cite with attribution — see how the data is put together.